2.Historathological change after chemotherapy of squamous cell carcinoma in head and neck:cob regimen
Young Kyun KIM ; Hwan Ho YEO ; Jae O CHO
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 1993;15(2):147-155
No abstract available.
Carcinoma, Squamous Cell
;
Drug Therapy
;
Head
5.A Case of Conjunctival Squamous Cell Carcinoma Similar with Herpetic Keratitis.
Journal of the Korean Ophthalmological Society 2001;42(11):1621-1625
PURPOSE: We reported a case of squamous cell carcinoma in a patient with chronic herpetic keratitis treated with Mitomycin C. METHODS: In a patient with 13-year recurrent chronic herpetic keratitis, we diagnosed invasive squamous cell carcinoma in papillary mass with no response of previous treatment by conjunctival biopsy. RESULTS: After surgical removal and chemotherapy of 0.04% topical Mitomycin C, the eye showed histopathological resolution of squamous cell carcinoma.
Biopsy
;
Carcinoma, Squamous Cell*
;
Drug Therapy
;
Humans
;
Keratitis, Herpetic*
;
Mitomycin
6.A Case of Squamous Cell Carcinoma of The Ovary Showing Complete Remission to Combination Chemotherapy Composed of Paclitaxel and Cisplatin.
Jin Dong JEON ; Eun Gyung CHOI ; Eun Mi JO ; Young Tae KIM ; Jae Wook KIM
Korean Journal of Obstetrics and Gynecology 2000;43(8):1492-1496
No abstract available.
Carcinoma, Squamous Cell*
;
Cisplatin*
;
Drug Therapy, Combination*
;
Female
;
Ovary*
;
Paclitaxel*
7.Neoadjuvant chemotherapy with 5-fluorouracial infusion and cisplatin for locally advanced, untreated squamous cell carcinoma of the head and neck.
Myung Jin KIM ; Kyoung Won KIM ; Yong Seok CHO ; Ho Kyun CHUNG ; Yung Jue BANG ; Dae Seog HEO
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1993;19(4):573-582
No abstract available.
Carcinoma, Squamous Cell*
;
Cisplatin*
;
Drug Therapy*
;
Head*
;
Neck*
9.Oral squamous cell carcinomas: state of the field and emerging directions.
Yunhan TAN ; Zhihan WANG ; Mengtong XU ; Bowen LI ; Zhao HUANG ; Siyuan QIN ; Edouard C NICE ; Jing TANG ; Canhua HUANG
International Journal of Oral Science 2023;15(1):44-44
Oral squamous cell carcinoma (OSCC) develops on the mucosal epithelium of the oral cavity. It accounts for approximately 90% of oral malignancies and impairs appearance, pronunciation, swallowing, and flavor perception. In 2020, 377,713 OSCC cases were reported globally. According to the Global Cancer Observatory (GCO), the incidence of OSCC will rise by approximately 40% by 2040, accompanied by a growth in mortality. Persistent exposure to various risk factors, including tobacco, alcohol, betel quid (BQ), and human papillomavirus (HPV), will lead to the development of oral potentially malignant disorders (OPMDs), which are oral mucosal lesions with an increased risk of developing into OSCC. Complex and multifactorial, the oncogenesis process involves genetic alteration, epigenetic modification, and a dysregulated tumor microenvironment. Although various therapeutic interventions, such as chemotherapy, radiation, immunotherapy, and nanomedicine, have been proposed to prevent or treat OSCC and OPMDs, understanding the mechanism of malignancies will facilitate the identification of therapeutic and prognostic factors, thereby improving the efficacy of treatment for OSCC patients. This review summarizes the mechanisms involved in OSCC. Moreover, the current therapeutic interventions and prognostic methods for OSCC and OPMDs are discussed to facilitate comprehension and provide several prospective outlooks for the fields.
Humans
;
Carcinoma, Squamous Cell/therapy*
;
Squamous Cell Carcinoma of Head and Neck
;
Mouth Neoplasms/therapy*
;
Head and Neck Neoplasms
;
Tumor Microenvironment
10.A Case of Squamous Cell Carcinoma of Bartholin's Gland.
Duck Yeong RO ; Hwa Jeong SHIN ; Gil Joong KIM ; Ji Young KWON ; Cheol Hoon PARK ; Yong Wook KIM ; Tae Eung KIM ; Jae Keun JUNG
Korean Journal of Obstetrics and Gynecology 2002;45(9):1595-1600
Carcinomas of Bartholin's gland are rare tumors that account for less than 1% of all gynecological malignancies. Two major histological types, squamous cell carcinoma and adenocarcinoma, account for 80% to 90% of primary cases. The remainders are adenosquamous carcinoma, adenoid cystic carcinoma and so on. We experienced a case of squamous cell carcinoma of the Bartholin's gland managed by wide local excision and chemotherapy with cisplatin and 5-fluorouracil (5-FU). We present this case with a brief review of the literatures.
Adenocarcinoma
;
Carcinoma, Adenoid Cystic
;
Carcinoma, Adenosquamous
;
Carcinoma, Squamous Cell*
;
Cisplatin
;
Drug Therapy
;
Fluorouracil